Table 10.
Compound | Biological Effect | Ref. |
---|---|---|
N-trans-caffeolyltyramine | Strong in vitro scavenging DPPH radical and ORAC antioxidant activity; LDL protection against in vitro oxidation; In vitro AChE and arginase inhibitory activity; In vivo anti-neuroinflammatory action; In vitro prevention of H2O2-induced cell death. |
[100] [103] [104] [107] [111] |
N-trans-feryoryltyramine | In vitro scavenging DPPH radical activity; In vivo anti-neuroinflammatory action. |
[103] [111] |
N-trans-caffeolyoctopamine | In vivo anti-neuroinflammatory action. | [111] |
N-trans-cumaroyltyramine | In vivo anti-neuroinflammatory action. | [111] |
Cannabisin A | In vitro scavenging DPPH radical activity; In vivo anti-neuroinflammatory action. |
[103] [111] |
Cannabisin B | Strong in vitro scavenging DPPH radical and ORAC antioxidant activity; LDL protection against in vitro oxidation; In vitro arginase inhibitory activity. |
[100] [104] [111] |
Cannabisin C | In vitro scavenging DPPH radical activity; In vivo anti-neuroinflammatory action. |
[103] [111] |
Cannabisin D | In vitro scavenging DPPH radical activity; In vivo anti-neuroinflammatory action. |
[103] [111] |
Cannabisin E | In vivo anti-neuroinflammatory action | [111] |
Cannabisin F | In vitro scavenging DPPH radical and ORAC antioxidant activity; In vivo anti-neuroinflammatory action; In vitro inhibition of the NFκB inflammatory pathway, activation of Nfr-2 antioxidant pathway and upregulation of SIRT1. |
[104] [110] [111] |
Cannabisin M | In vitro scavenging DPPH radical activity; In vivo anti-neuroinflammatory action. |
[103] [111] |
Isocannabisin N | In vivo anti-neuroinflammatory action | [111] |
Grossamide | In vitro inhibition of the NFκB inflammatory pathway. In vivo anti-neuroinflammatory action; |
[109] [111] |
3,3′-demethyl-grossamide | In vitro scavenging DPPH radical activity; In vitro AChE inhibitory activity; In vivo anti-neuroinflammatory action. |
[103] [111] |
3,3′-demethylheliotropamide | In vitro AChE and arginase inhibitory activity. | [103] |
Sativamides A | In vitro reduction of ER stress-induced cell death. | [106] |
Sativamides B | In vitro reduction of ER stress-induced cell death. | [106] |
4-((E)-p-coumaroylamino)butan-1-ol | In vitro inhibition of TNF-α release. | [105] |
Cumaroylaminobutanol glucopyranoside | In vitro inhibition of TNF-α release; In vitro inhibition of the NFκB inflammatory pathway and activation of Nfr-2 antioxidant pathway. |
[105] [108] |